Department of Gastroenterology and Hepatology, Radboudumc, Nijmegen, Gelderland, The Netherlands
Department of Gastroenterology and Hepatology, Radboudumc, Nijmegen, Gelderland, The Netherlands.
BMJ Open Gastroenterol. 2023 May;10(1). doi: 10.1136/bmjgast-2023-001136.
Screening for early oesophageal adenocarcinoma (OAC), including its precursor Barrett's oesophagus (BO), can potentially reduce OAC-related morbidity and mortality. This study explores Dutch at-risk individuals' views of screening an at-risk population for BO/OAC.
We invited 372 individuals with risk factors for OAC from primary care practices, 73 individuals with surveillance experience, and 221 participants of previous studies (BO/OAC screening trial or survey) to participate in focus groups. Transcripts were inductively and thematically analysed by two independent researchers.
A total of 50 individuals (42% with gastro-oesophageal reflux symptoms) of 50-75 years participated. Themes that were raised included: theme 1 'screening intentions' describing participants' motivation to be screened (eg, early diagnosis, potential reassurance, physician recommendation, and knowing someone with cancer) or decline screening (eg, anticipated discomfort or suboptimal accuracy of the test); theme 2 'risk-based eligibility' describing the tension between effectiveness (eg, targeting high-risk individuals) and inclusivity (eg, making screening available for everyone); theme 3 'distributive justice', in which the pressure of a potential new screening programme on healthcare resources was discussed; and theme 4 'information needs' describing the perceived lack of information access and individuals' preference to discuss screening with their general practitioner.
Individuals not only expressed high willingness to be screened but also voiced the concern that a new screening programme may pressure limited healthcare resources. If implemented, it is crucial to develop educational materials that meet the public's information needs and explain the test procedures and eligibility criteria while avoiding stigmatising language.
筛查早期食管腺癌(OAC),包括其前体 Barrett 食管(BO),可能降低 OAC 相关发病率和死亡率。本研究探讨了荷兰高危人群对筛查高危人群患 BO/OAC 的看法。
我们邀请了来自初级保健机构的 372 名 OAC 高危个体、73 名有监测经验的个体以及 221 名之前研究的参与者(BO/OAC 筛查试验或调查)参加焦点小组。两位独立研究人员对转录本进行了归纳和主题分析。
共有 50 名 50-75 岁的个体(42%有胃食管反流症状)参加了研究。提出的主题包括:主题 1“筛查意愿”,描述了参与者进行筛查的动机(例如,早期诊断、潜在的安心、医生的建议和认识患有癌症的人)或拒绝筛查(例如,预期的不适或测试的准确性不理想);主题 2“基于风险的资格”,描述了有效性(例如,针对高风险个体)和包容性(例如,为所有人提供筛查)之间的紧张关系;主题 3“分配正义”,讨论了潜在新筛查计划对医疗保健资源的压力;主题 4“信息需求”,描述了对缺乏信息获取的感知和个体倾向于与他们的全科医生讨论筛查的情况。
个体不仅表达了高度的筛查意愿,还表示担心新的筛查计划可能会给有限的医疗保健资源带来压力。如果实施,开发满足公众信息需求的教育材料并解释测试程序和资格标准至关重要,同时避免使用污名化的语言。